Nutritional supplements and extracts like Banaba have benefits and are used by cancer patients and those at-genetic risk of cancer. There is limited or hardly any clinical data available for use of nutritional supplements and foods in cancer patients. Generating clinical evidence of efficacy for cancer through a randomized clinical trial is further infeasible due to variations in genetics and cancer chemotherapy treatments across cancer patients. Hence a different and new approach is needed to find out for which cancers you should not take Banaba supplement and why should not take them?
Is it okay to take Banaba extracts or supplements for all cancer indications and any chemotherapy treatment? A common belief but a myth is that everything natural can only be of benefit and do no harm. For example, the use of grapefruit with certain medications is not recommended. Another example is the use of spinach with some blood thinning medications can cause adverse interactions and hence to be avoided. For cancer, nutrition including plant-based foods and supplements can influence outcomes and hence an extremely important decision which needs to be made. Hence NIH-National Cancer Institute has a website for nutrition for cancer care for patients which are generalized recommendations and not personalized for cancer indication and treatments.
A frequently asked question by cancer patients and those at-risk is “What Foods and Nutritional Supplements could be beneficial over others for me?”. “Who should not take an extract or supplement and why?”. Generic guidelines like eating only plant-based-foods or avoiding all sugar or adopting a keto diet is a good start but not actionable and personalized enough.
To find answers to questions on extracts and nutritional supplements and foods requires knowledge of contained active ingredients; genetic mutation prevalence for cancer indication; understanding of underlying cancer biology; chemotherapy treatments and mechanism of actions of active ingredients.
Taking Banaba extracts or nutritional supplements may benefit Primary Non-Small Cell Lung Cancer patients on Erlotinib treatment over Poppy nutritional supplements. But Banaba supplements or Banaba extracts offer less benefit if on Cyclophosphamide treatment for Primary Gastrointestinal Neuroendocrine Tumors compared to Costus. Similarly, taking nutritional supplements Banaba may benefit healthy individuals who are at genetic risk of cancer due to mutation of gene HRAS over Coconut. But avoid nutritional supplements Banaba when at genetic risk of cancer due to mutation of gene JAK2.
The takeaway being – cancer, genomics, treatments and other personalized factors will influence decision making to questions like: Are extracts or nutritional supplements Banaba beneficial and should not be taken? Why should Banaba be not taken? Who should not take Banaba? What are side effects of Banaba with Cyclophosphamide chemotherapy? What are the benefits of Banaba for cancer? Can Banaba help fight cancer and so on.
Whenever there are changes in chemotherapy treatments or cancer tissue genetics – the nutrition may change and hence needs to be re-evaluated. Do consider factors like cancer indication, ongoing chemotherapy treatments and nutritional supplements, age, gender, weight, height, lifestyle and genetics for personalization of nutrition.
Use of nutritional supplements – vitamins, herbs, minerals, probiotics, and other specialty categories are increasing. Supplements are high concentrations of active ingredients which are also found in different foods. Difference between supplements and foods being that foods contain more than one active ingredient at much lower concentrations. Every active ingredient in an extract or nutritional supplement or food has a unique mechanism of action which can influence nutrition decisions.
These are some example questions which nutrition planning should help answer for you. Should you take supplements Banaba? Should you take it when at genetic risk of cancer for mutation of gene HRAS? Should you take it when at genetic risk of cancer for mutation of gene JAK2? Should you take it when diagnosed with Primary Gastrointestinal Neuroendocrine Tumors? Should you take it when diagnosed with Primary Non-Small Cell Lung Cancer? Should you take it when on Erlotinib treatment? Should you continue taking it if you change your treatment from Erlotinib to Cyclophosphamide? So a general explanation like – it is organic and plant-based or it increases immunity is not sufficient information for making a decision of use of Banaba extracts and nutritional supplements.
Genetic variations across cancer patients can be different and hence no two cancers are alike. The improved availability of “personalized to genetics” chemotherapy treatments and cancer disease monitoring via blood and saliva have been significant factors to improve outcomes. The earlier the lifestyle and treatment intervention – the better the influence on outcome. Genetic testing has the potential to assess cancer risk and susceptibility early. But for at-risk individuals besides regular monitoring in most cases there are no therapeutic treatment intervention options available. After diagnosis with cancer such as Primary Non-Small Cell Lung Cancer or Primary Gastrointestinal Neuroendocrine Tumors, the treatments get personalized to tumor genomics and factors like staging of disease, age and gender. During cancer remission (after treatment cycle is complete) – monitoring is used for assessment of any relapse and accordingly decide on next steps. A large majority of cancer patients and those at-risk may take nutritional supplements like Banaba.
So the question is that are all genetic risks and cancer indications to be considered uniformly when making decisions on the use of Banaba extracts or nutritional supplements? Are the biochemical pathway implications of genetic risk for cancer due to mutation of gene HRAS the same as due to mutation of gene JAK2? Are the implications of Primary Non-Small Cell Lung Cancer the same as Primary Gastrointestinal Neuroendocrine Tumors? Is it one and the same if you are on treatment with Cyclophosphamide or Erlotinib?
Banaba – An Extract or Nutritional Supplement
Banaba (Lagerstroemia speciosa), also known as Crepe myrtle, Pride of India, Queen’s crepe myrtle, and Queen’s flower is a tree native to the Philippines and Southeast Asia. The different parts of the tree including its leaves, roots, fruits and bark are considered to have medicinal properties. Following are some of the potential health benefits of Banaba:
- May have strong antioxidant properties (S M Saumya and P Mahaboob Basha, Indian J Exp Biol., 2011)
- May help reduce blood sugar (K S Kesavanarayanan et al, Eur Rev Med Pharmacol Sci., 2012)
- May help reduce cisplatin induced kidney damage (T T Priya et al, J Basic Clin Physiol Pharmacol., 2007)
- May have antimicrobial effects (Tasnuva Sharmin et al, BMC Complement Altern Med., 2018)
- May help reduce obesity (Agung Heru Karsono et al, J Exp Pharmacol., 2019)
- May help reduce the risk of cardiovascular diseases (Arrigo Francesco Giuseppe Cicero, High Blood Press Cardiovasc Prev., 2017)
Banaba supplements contain many active ingredients including Gallic Acid, Beta-sitosterol, Ellagic Acid, Corosolic Acid and Maslinic Acid at different concentration levels. The molecular pathways which are regulated by Banaba include Extracellular Matrix Remodelling, Oxidative Stress, Cytokine Signaling and MAPK Signaling. These biochemical pathways directly or indirectly regulate specific cancer molecular endpoints like growth, spread and death of cancer cells. Because of this biological regulation – for cancer nutrition, the right choice of supplements like Banaba individually or in combination is an important decision to be made. When making decisions on the use of supplement Banaba over other nutritional supplements – do consider all these factors.
Who Should not take Banaba Supplements and Why?
There is no easy way to answer the question “For which cancers should I not chooseBanaba nutritional supplements”. Just like the same chemotherapy treatment does not work across patients, for similar reasons Banaba in comparison with other nutritional supplements may be beneficial or not. Along with which cancer and associated genetics – the ongoing treatments, lifestyle habits, height, weight and food allergies are all factors in deciding if Banaba should be avoided or not and why.
1. Will Banaba Supplements benefit Primary Gastrointestinal Neuroendocrine Tumors patients undergoing Cyclophosphamide treatment?
Primary Gastrointestinal Neuroendocrine Tumors is characterized and driven by specific genetic mutations like ALK, APC and DAXX leading to biochemical pathway changes in Oxidative Stress, Growth Factor Signaling, JAK-STAT Signaling, Angiogenesis, Androgen Signaling and Apoptosis. A cancer treatment like Cyclophosphamide works through a specific pathway mechanism of action. The goal is to have a good overlap between the treatment and cancer driving pathways for a personalized approach which is effective. In such a condition any food or nutritional supplement which has a contrary effect to the treatment or reduces the overlap should be avoided. As an example, Banaba supplement should not be taken for Primary Gastrointestinal Neuroendocrine Tumors along with treatment Cyclophosphamide. Banaba supplement impacts the biochemical pathway called Oxidative Stress which either promotes drivers of the disease and/or nullifies the treatment effect. Some of the factors which should be considered when choosing nutrition are type of cancer, treatments and supplements being taken currently (if any
2. Will Banaba Supplements benefit Primary Non-Small Cell Lung Cancer Patients undergoing Erlotinib Treatment?
Primary Non-Small Cell Lung Cancer is characterized and driven by specific genetic mutations like CSMD2, LRP2 and CACNA1E leading to biochemical pathway changes in Extracellular Matrix Remodelling. A cancer treatment like Erlotinib works through specific pathway mechanisms. The goal is to have a good overlap between the treatment and cancer driving pathways for a personalized approach. In such a condition any food or nutritional supplement which supports treatment action or improves the overlap should be considered. As an example, Banaba supplements should be considered for Primary Non-Small Cell Lung Cancer along with the treatment Erlotinib. Banaba supplement impacts pathways/processes like Extracellular Matrix Remodelling which either obstruct drivers of Primary Non-Small Cell Lung Cancer and/or improve Erlotinib treatment effect.
Foods to Eat After Cancer Diagnosis!
No two cancers are the same. Go beyond the common nutrition guidelines for everyone and make personalized decisions about food and supplements with confidence.
3. What about Banaba Supplements for Healthy Individuals with JAK2 Mutation associated Genetic Risk?
Different companies offer panels of genes to be tested for assessing genetic risk to different cancers. These panels cover genes associated with cancers of the breast, ovary, uterus, prostate, and gastrointestinal system and others. Genetic testing of these genes may confirm a diagnosis and help guide treatment and management decisions. Identification of a disease-causing variant may also guide testing and diagnosis of at-risk relatives. JAK2 is one of the genes generally available in panels for cancer risk testing.
JAK2 mutation causes biochemical pathways/processes like Cytokine Signaling, JAK-STAT Signaling and Immune Checkpoints to get impacted. These pathways are direct or indirect drivers of cancer molecular endpoints. Banaba should not be taken when the genetic panel identifies mutation of JAK2 for Myeloproliferative Neoplasms. Banaba impacts pathways/processes like Cytokine Signaling and creates adverse conditions with JAK2.
4. What about Banaba Supplements for Healthy Individuals with HRAS Mutation associated Genetic Risk?
HRAS is one of the genes available in panels for cancer risk testing. HRAS mutation causes biochemical pathways/processes like MAPK Signaling and RAS-RAF Signaling to get impacted. These pathways are direct or indirect drivers of cancer molecular endpoints. Banaba supplements may be considered when the genetic panel identifies mutations in HRAS for Pheochromocytoma And Paraganglioma. Banaba impacts pathways/processes like MAPK Signaling and creates a canceling effect in those individuals with HRAS mutation.
* Other Factors are also included like BMI, Treatments, Lifestyle Habits
It is important to remember that cancer chemotherapy treatments and nutrition are never the same for everyone. Food and nutritional supplements like Banaba are chosen by you and can influence outcomes.
“What should I eat?” is a commonly asked question by cancer patients and those at-risk. The answer to this question depends on cancer indication, underlying genetics, current chemotherapy treatments, food allergies, lifestyle information, and food preferences.
The addon.life approach to nutrition personalization uses knowledge of active ingredients contained in foods and nutritional supplements, cancer biology, chemotherapy treatment action and genetic mutation prevalence across cancer indications. addon.life team of clinicians, clinical scientists and engineers are experts in cancer biology focusing only on nutrition personalization for cancer patients and those at-risk.
What food you eat and which supplements you take is a decision you make. Your decision should include consideration of the cancer gene mutations, which cancer, ongoing treatments and supplements, any allergies, lifestyle information, weight, height and habits.
The nutrition planning for cancer from addon is not based on internet searches. It automates the decision making for you based on molecular science implemented by our scientists and software engineers. Irrespective of whether you care to understand the underlying biochemical molecular pathways or not - for nutrition planning for cancer that understanding is needed.
Get started NOW with your nutrition planning by answering questions on the name of cancer, genetic mutations, ongoing treatments and supplements, any allergies, habits, lifestyle, age group and gender.
- Indeno[1,2-b]indole derivatives as a novel class of potent human protein kinase CK2 inhibitors.
- cBioPortal for Cancer Genomics
- Reactive oxygen species-mediated activation of AMP-activated protein kinase and c-Jun N-terminal kinase plays a critical role in beta-sitosterol-induced apoptosis in multiple myeloma U266 cells.
- cBioPortal for Cancer Genomics
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.
- Cyclophosphamide-induced apoptosis in COV434 human granulosa cells involves oxidative stress and glutathione depletion.
- Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer.
- Evaluation of pentacyclic triterpenes found in Perilla frutescens for inhibition of skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types.
- Ellagic acid exerts antitumor effects via the PI3K signaling pathway in endometrial cancer.
Personalized Nutrition for Cancer!
Cancer changes with time. Customize and modify your nutrition based on cancer indication, treatments, lifestyle, food preferences, allergies and other factors.